Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Lawsuit Filed by the Schal Law Firm
11:45am, Wednesday, 03'rd Jul 2024
LOS ANGELES , July 3, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Marinus Pharmaceuticals, Inc. ("Ma
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNS
11:30am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit - MRNS
11:00am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
The Schall Law Firm Begins An Investigation Into Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Reach Out
11:00am, Wednesday, 03'rd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) Shareholders
11:00am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:40am, Wednesday, 03'rd Jul 2024
LOS ANGELES, July 03, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Marinus Pharmaceuticals, Inc.
August 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNS
09:15pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Shareholders with losses of $100,000 or more are encouraged to contact the firm Shareholders with losses of $100,000 or more are encouraged to contact the firm
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
05:00pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit – MRNS
04:45pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
The Schall Law Firm Initiates A Probe Into Marinus Pharmaceuticals Inc And Motivates Affected Investors To Connect
04:30pm, Tuesday, 02'nd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
12:27pm, Tuesday, 02'nd Jul 2024
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS) of a class action securities lawsuit.
